Vivaterm - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 168,873 | 201,804 | 138,570 | 177,020 | 208,241 | 155,831 | 170,721 | 158,513 |
| Profit before tax | - | - | -7,774 | 367 | -1,935 | 94 | 3,268 | 1,427 |
| Net profit | 164 | 3,724 | -7,774 | 349 | -1,935 | 89 | 3,105 | 1,328 |
| Equity | 39,084 | 42,544 | 34,771 | 35,121 | 33,185 | 33,772 | 36,261 | 37,589 |
| Liabilities | 18,305 | 36,011 | 37,709 | 20,181 | 23,722 | 1,812 | 31,838 | 13,614 |
| Non-current assets | 16,069 | 12,626 | 9,184 | 5,741 | 2,298 | 3 | 3 | 3 |
| Current assets | 41,166 | 65,929 | 63,183 | 49,561 | 54,602 | 35,581 | 68,096 | 51,141 |
| Total assets | 57,235 | 78,555 | 72,367 | 55,302 | 56,900 | 35,584 | 68,099 | 51,144 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 9,756 | 7,804 | 9,293 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +27.2% | +19.5% | -31.3% | +27.7% | +17.6% | -25.2% | +9.6% | -7.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.3% | 4.7% | -10.7% | 0.6% | -3.4% | 0.3% | 4.6% | 2.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.4% | 8.8% | -22.4% | 1.0% | -5.8% | 0.3% | 8.6% | 3.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.1% | 1.8% | -5.6% | 0.2% | -0.9% | 0.1% | 1.8% | 0.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | -5.6% | 0.2% | -0.9% | 0.1% | 1.9% | 0.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.8 | 1.1 | 0.6 | 0.7 | 0.1 | 0.9 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 42,218 | 48,433 | 46,190 | 59,007 | 69,414 | 51,944 | 56,907 | 52,838 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vivaterm - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-21 | 2026-07-27 | 321.80 |
| 2026-07-19 | 2026-07-20 | 495.70 |
| 2026-07-16 | 2026-07-17 | 495.70 |
| 2026-01-21 | 2026-02-01 | 1.89 |
| 2025-12-29 | 2025-12-29 | 219.08 |
| 2025-12-16 | 2025-12-28 | 501.97 |
| 2025-07-24 | 2025-08-03 | 0.08 |
| 2025-04-24 | 2025-04-29 | 0.23 |
| 2025-02-18 | 2025-02-19 | 287.15 |
| 2023-07-26 | 2023-08-02 | 1.13 |
| 2023-07-24 | 2023-07-25 | 1.17 |
| 2023-05-16 | 2023-05-23 | 433.91 |
| 2022-01-18 | 2022-02-06 | 0.16 |
Vivaterm - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vivaterm, UAB (company code 302317027) is a Private Limited Liability Company engaged in activities of agents involved in the wholesale of other particular products. In the latest financial year, 2025, the company generated revenue of €158.5K and net profit of €1.3K, which corresponded to a profit margin of 0.8%. Revenue declined by 7.2% year on year from €170.7K in 2024, while the 2-year change versus 2023 was +1.7%, indicating a broadly stable top line over the period. Profitability improved significantly in 2024, when net profit reached €3.1K, before easing in 2025. Balance sheet size decreased from €68.1K in 2024 to €51.1K in 2025, while equity increased slightly to €37.6K and liabilities fell to €13.6K. The equity ratio was 73.5%, debt-to-equity was 0.36, asset turnover stood at 3.10x, ROE was 3.5%, and ROA was 2.6%. Revenue per employee was €52.8K, with profit per employee of €443, pointing to modest but positive operating efficiency in 2025.